miR ‐221/222 cluster expression improves clinical stratification of non‐muscle invasive bladder cancer (TaT1) patients' risk for short‐term relapse and progression

In conclusion, the expression of miR‐221/222 cluster is deregulated in bladder tumors and miR‐222 overexpression results to a superior positive prediction of TaT1 patients' short‐term relapse and progression. This article is protected by copyright. All rights reserved.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fgcc.22516

Source: Genes, Chromosomes and Cancer - November 27, 2017 Category: Cancer & Oncology Authors: Foteini D. Tsikrika, Margaritis Avgeris, Panagiotis K. Levis, Theodoros Tokas, Konstantinos Stravodimos, Andreas Scorilas Tags: Research Article Source Type: research